Editas Medicine (EDIT) Asset Utilization Ratio (2016 - 2025)

Editas Medicine (EDIT) has reported Asset Utilization Ratio for 10 consecutive years, with 0.22 the latest figure, recorded in Q3 2025.

• In Q3 2025, Asset Utilization Ratio rose 29.75% year-over-year to 0.22; the TTM figure through Sep 2025 stood at 0.22 (up 29.75% YoY), while the FY2024 annual figure was 0.08, down 50.14% from the prior year.
• Asset Utilization Ratio rose to 0.22 in Q3 2025 per EDIT's latest filing, from 0.16 in the prior quarter.
• Across five years, Asset Utilization Ratio topped out at 0.22 in Q3 2025 and bottomed at 0.03 in Q3 2021.
• Historically, Asset Utilization Ratio has averaged 0.1 across 5 years, with a median of 0.1 in 2024.
• Annual changes were most pronounced in 2021 — Asset Utilization Ratio tumbled 77.26% — and 2024, when it jumped 323.12%.
• Editas Medicine's Asset Utilization Ratio stood at 0.04 in 2021, then gained by 2.94% to 0.04 in 2022, then soared by 312.75% to 0.16 in 2023, then sank by 37.95% to 0.1 in 2024, then surged by 132.95% to 0.22 in 2025.
• Business Quant data shows EDIT's Asset Utilization Ratio at 0.22 in Q3 2025, 0.16 in Q2 2025, and 0.12 in Q1 2025.